Labcorp Holdings, Inc. (LH)
361.39
-6.77
(-1.84%)
USD |
NYSE |
Oct 30, 16:00
361.76
+0.36
(+0.10%)
After-Hours: 20:00
Labcorp Holdings Cash from Operations (Quarterly) : 563.80M for Sept. 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 563.80M |
| June 30, 2026 | 445.50M |
| March 31, 2026 | 191.50M |
| December 31, 2025 | 614.20M |
| September 30, 2025 | 387.20M |
| June 30, 2025 | 620.60M |
| March 31, 2025 | 18.50M |
| December 31, 2024 | 777.20M |
| September 30, 2024 | 277.30M |
| June 30, 2024 | 561.10M |
| March 31, 2024 | -29.80M |
| December 31, 2023 | 579.60M |
| September 30, 2023 | 275.50M |
| June 30, 2023 | 351.40M |
| March 31, 2023 | 121.20M |
| December 31, 2022 | 653.60M |
| September 30, 2022 | 373.80M |
| June 30, 2022 | 572.50M |
| March 31, 2022 | 356.00M |
| December 31, 2021 | 697.50M |
| September 30, 2021 | 767.30M |
| June 30, 2021 | 487.20M |
| March 31, 2021 | 1.158B |
| December 31, 2020 | 774.60M |
| September 30, 2020 | 786.20M |
| Date | Value |
|---|---|
| June 30, 2020 | 370.70M |
| March 31, 2020 | 203.80M |
| December 31, 2019 | 4.30M |
| September 30, 2019 | 650.00M |
| June 30, 2019 | 364.90M |
| March 31, 2019 | 425.50M |
| December 31, 2018 | 486.40M |
| September 30, 2018 | 297.00M |
| June 30, 2018 | 367.30M |
| March 31, 2018 | 154.70M |
| December 31, 2017 | 565.00M |
| September 30, 2017 | 396.70M |
| June 30, 2017 | 310.50M |
| March 31, 2017 | 225.90M |
| December 31, 2016 | 448.90M |
| September 30, 2016 | 249.90M |
| June 30, 2016 | 349.50M |
| March 31, 2016 | 127.60M |
| December 31, 2015 | 384.60M |
| September 30, 2015 | 288.00M |
| June 30, 2015 | 396.70M |
| March 31, 2015 | -86.90M |
| December 31, 2014 | 189.70M |
| September 30, 2014 | 175.60M |
| June 30, 2014 | 207.30M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Quest Diagnostics, Inc. | 611.00M |
| OPKO Health, Inc. | -43.50M |
| Myriad Genetics, Inc. | -8.30M |
| Psychemedics Corp. | -- |
| NeoGenomics, Inc. | -8.885M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -433.70M |
| Cash from Financing (Quarterly) | -10.00M |
| Free Cash Flow | 1.287B |
| Free Cash Flow Per Share (Quarterly) | 5.052 |
| Free Cash Flow to Equity (Quarterly) | 402.40M |
| Free Cash Flow to Firm (Quarterly) | 459.61M |
| Free Cash Flow Yield | 4.32% |